Literature DB >> 23692556

Expression of integrin and CD44 receptors recognising osteopontin in the normal and LPS-lesioned rat substantia nigra.

Sara Ailane1, Philip Long, Peter Jenner, Sarah Rose.   

Abstract

The multifunctional protein osteopontin (OPN) is expressed in the substantia nigra (SN) and protects nigral dopaminergic neurones against toxic insult in animal models of Parkinson's disease, although the mechanisms involved are uncertain. In the periphery, OPN regulates inflammatory processes by interacting with integrin and CD44 receptors but the presence and distribution of these sites in SN is unknown. We investigated the expression of integrin receptor subunits and CD44 receptors in the normal SN and after induction of inflammation by lipopolysaccharide (LPS), and their interaction with OPN. In normal rat SN, integrin αv , β3 and β1 , and CD44, receptors were expressed on neurones including TH-positive cells but not on glia. LPS administration induced a loss of TH-positive neurones in SN and increased expression of glial cells as shown by GFAP, OX-6 and ED-1 immunoreactivity. In LPS-lesioned SN, there was up-regulation of the expression of integrin β3 and CD44 receptors. Co-localisation studies showed that this related to their increased expression on OX-6-, ED-1- and GFAP-positive cells. Furthermore, OPN interacted with integrin and CD44 receptors in the normal rat SN as demonstrated by co-immunoprecipitation and pull-down techniques. These data show that integrin and CD44 receptors are present on neurones in normal rat SN and that they are up-regulated on glial cells following LPS-mediated inflammation in SN, suggesting that they are functionally important in the inflammatory process. The interaction of OPN with these receptors suggests a role in the neuroprotective effect of this protein in the LPS model of Parkinson's disease.
© 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  Parkinson's disease; brain; glia; inflammation; neuroprotection

Mesh:

Substances:

Year:  2013        PMID: 23692556     DOI: 10.1111/ejn.12231

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  11 in total

1.  The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins.

Authors:  Mark S Moehle; João Paulo Lima Daher; Travis D Hull; Ravindra Boddu; Hisham A Abdelmotilib; James Mobley; George T Kannarkat; Malú G Tansey; Andrew B West
Journal:  Hum Mol Genet       Date:  2015-04-29       Impact factor: 6.150

2.  Matrix Metalloproteinase 9 and Osteopontin Interact to Support Synaptogenesis in the Olfactory Bulb after Mild Traumatic Brain Injury.

Authors:  Melissa A Powell; Raiford T Black; Terry L Smith; Thomas M Reeves; Linda L Phillips
Journal:  J Neurotrauma       Date:  2019-01-10       Impact factor: 5.269

Review 3.  Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease.

Authors:  Kevin M Budge; Matthew L Neal; Jason R Richardson; Fayez F Safadi
Journal:  Mol Neurobiol       Date:  2017-08-30       Impact factor: 5.590

4.  Extracellular matrix hyaluronan signals via its CD44 receptor in the increased responsiveness to mechanical stimulation.

Authors:  L F Ferrari; D Araldi; O Bogen; J D Levine
Journal:  Neuroscience       Date:  2016-03-18       Impact factor: 3.590

5.  Cortical neurons are a prominent source of the proinflammatory cytokine osteopontin in HIV-associated neurocognitive disorders.

Authors:  Katie Silva; Calixto Hope-Lucas; Tyesha White; Tai-Kyung Hairston; Tatenda Rameau; Amanda Brown
Journal:  J Neurovirol       Date:  2015-01-31       Impact factor: 2.643

6.  Osteopontin Peptide Icosamer Containing RGD and SLAYGLR Motifs Enhances the Motility and Phagocytic Activity of Microglia.

Authors:  Il-Doo Kim; Hahnbie Lee; Yin-Chuan Jin; Ja-Kyeong Lee
Journal:  Exp Neurobiol       Date:  2017-12-11       Impact factor: 3.261

7.  Integrin β3 and CD44 levels determine the effects of the OPN-a splicing variant on lung cancer cell growth.

Authors:  Shih-Jung Sun; Chun-Chi Wu; Gwo-Tarng Sheu; Hui-Yi Chang; Mei-Yu Chen; Yu-Ying Lin; Cheng-Yen Chuang; Shih-Lan Hsu; Jinghua Tsai Chang
Journal:  Oncotarget       Date:  2016-08-23

8.  The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor.

Authors:  Matthew L Neal; Alexa M Boyle; Kevin M Budge; Fayez F Safadi; Jason R Richardson
Journal:  J Neuroinflammation       Date:  2018-03-08       Impact factor: 8.322

9.  Molecular insights in the pathogenesis of classical Ehlers-Danlos syndrome from transcriptome-wide expression profiling of patients' skin fibroblasts.

Authors:  Nicola Chiarelli; Giulia Carini; Nicoletta Zoppi; Marco Ritelli; Marina Colombi
Journal:  PLoS One       Date:  2019-02-04       Impact factor: 3.240

10.  Involvement of the accumbal osteopontin-interacting transmembrane protein 168 in methamphetamine-induced place preference and hyperlocomotion in mice.

Authors:  Kequan Fu; Yoshiaki Miyamoto; Kazuya Otake; Kazuyuki Sumi; Eriko Saika; Shohei Matsumura; Naoki Sato; Yuka Ueno; Seunghee Seo; Kyosuke Uno; Shin-Ichi Muramatsu; Atsumi Nitta
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.